Anthony R White Selected Research

Trace Elements (Biometals)

4/2022	Biometal Dyshomeostasis in Olfactory Mucosa of Alzheimer's Disease Patients.
1/2021	Increased iron content in the heart of the Fmr1 knockout mouse.
1/2018	CuII(atsm) Attenuates Neuroinflammation.
1/2017	Copper and Alzheimer's Disease.
10/2016	X-ray fluorescence microscopic measurement of elemental distribution in the mouse retina with age.
4/2014	Deregulation of biometal homeostasis: the missing link for neuronal ceroid lipofuscinoses?
2/2014	Deregulation of subcellular biometal homeostasis through loss of the metal transporter, Zip7, in a childhood neurodegenerative disorder.
1/2014	Neuroprotective copper bis(thiosemicarbazonato) complexes promote neurite elongation.
6/2013	Altered biometal homeostasis is associated with CLN6 mRNA loss in mouse neuronal ceroid lipofuscinosis.
1/2013	Biometals in rare neurodegenerative disorders of childhood.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anthony R White Research Topics

Disease

45	Alzheimer Disease (Alzheimer's Disease) 04/2022 - 01/2002
28	Neurodegenerative Diseases (Neurodegenerative Disease) 03/2022 - 03/2003
16	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 03/2022 - 04/2006
13	Neoplasms (Cancer) 04/2019 - 01/2008
11	Parkinson Disease (Parkinson's Disease) 03/2022 - 01/2008
8	Neuroblastoma 04/2019 - 06/2006
7	Cognitive Dysfunction 04/2022 - 11/2007
5	Neuroinflammatory Diseases 01/2021 - 01/2013
5	Neuronal Ceroid-Lipofuscinoses (Neuronal Ceroid Lipofuscinosis) 10/2018 - 01/2013
5	Inflammation (Inflammations) 01/2018 - 08/2012
5	Amyloid Plaque 01/2017 - 03/2003
5	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 01/2017 - 05/2010
5	Prion Diseases (Transmissible Spongiform Encephalopathies) 05/2013 - 06/2002
4	Brain Diseases (Brain Disorder) 04/2022 - 01/2012
4	Motor Neuron Disease (Primary Lateral Sclerosis) 04/2014 - 03/2012
2	Disease Progression 02/2022 - 04/2010
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2020 - 01/2018
2	Retinal Degeneration 10/2018 - 10/2016
2	Stroke (Strokes) 01/2017 - 01/2012
2	Frontotemporal Dementia (Semantic Dementia) 01/2017 - 03/2012
2	Ischemia 01/2017 - 04/2004
2	Hypoxia (Hypoxemia) 10/2015 - 12/2011
1	Memory Disorders (Memory Loss) 08/2021
1	Fragile X Syndrome (Martin Bell Syndrome) 01/2021
1	Autism Spectrum Disorder 01/2021
1	Intellectual Disability (Idiocy) 01/2021
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 04/2019
1	Encephalitis (Encephalitis, Rasmussen) 01/2018
1	Brain Injuries (Brain Injury) 01/2017
1	Ischemic Stroke 01/2017
1	Brain Ischemia (Cerebral Ischemia) 01/2017
1	Spinal Muscular Atrophy (Progressive Muscular Atrophy) 01/2016
1	Renal Cell Carcinoma (Grawitz Tumor) 10/2015
1	Huntington Disease (Huntington's Disease) 08/2014

Drug/Important Bio-Agent (IBA)

30	CopperIBA 01/2021 - 01/2002
25	MetalsIBA 04/2022 - 11/2002
23	Proteins (Proteins, Gene)FDA Link 04/2022 - 01/2002
21	Amyloid beta-PeptidesIBA 01/2022 - 06/2002
17	Trace Elements (Biometals)IBA 04/2022 - 04/2004
9	Amyloid (Amyloid Fibrils)IBA 01/2021 - 01/2002
8	IronIBA 08/2021 - 11/2002
7	Pharmaceutical PreparationsIBA 03/2022 - 01/2004
7	ZincIBA 10/2015 - 11/2005
6	Superoxide Dismutase-1IBA 01/2018 - 04/2006
6	Peptides (Polypeptides)IBA 02/2009 - 06/2002
5	copper (II) diacetyl- di(N(4)- methylthiosemicarbazone)IBA 04/2019 - 02/2011
5	LigandsIBA 10/2015 - 11/2007
4	Biomarkers (Surrogate Marker)IBA 04/2022 - 04/2010
4	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 06/2002
4	Prion ProteinsIBA 01/2021 - 06/2002
4	DNA-Binding Proteins (DNA Binding Protein)IBA 01/2017 - 01/2013
3	RNA (Ribonucleic Acid)IBA 04/2022 - 01/2013
3	Glutathione (Reduced Glutathione)IBA 01/2018 - 03/2003
3	AntioxidantsIBA 01/2017 - 03/2003
3	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2017 - 01/2013
3	PrionsIBA 05/2013 - 03/2003
3	Coordination ComplexesIBA 10/2011 - 11/2009
3	IonsIBA 10/2011 - 02/2008
2	LipofuscinIBA 10/2018 - 04/2014
2	EnzymesIBA 01/2018 - 05/2015
2	CatecholaminesIBA 01/2018 - 12/2012
2	ThiosemicarbazonesIBA 01/2017 - 12/2011
2	Deferoxamine (Desferal)FDA LinkGeneric 01/2017 - 07/2013
2	Glycogen Synthase (Synthase I)IBA 08/2014 - 01/2011
2	LipidsIBA 04/2014 - 01/2008
2	Clioquinol (Vioform)FDA Link 01/2014 - 01/2008
2	IonophoresIBA 01/2014 - 03/2011
2	ManganeseIBA 01/2013 - 07/2010
2	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 12/2010 - 11/2005
2	Reducing AgentsIBA 04/2004 - 10/2002
1	Leucine (L-Leucine)FDA Link 02/2022
1	PyrinIBA 02/2022
1	InflammasomesIBA 02/2022
1	SynucleinsIBA 01/2021
1	Particulate MatterIBA 01/2020
1	PolyaminesIBA 04/2019
1	EthaneIBA 04/2019
1	Biological ProductsIBA 04/2019
1	Retinal Pigments (Pigments, Visual)IBA 10/2018
1	LipopolysaccharidesIBA 01/2018
1	NexusIBA 01/2018
1	MetallothioneinIBA 01/2018
1	Heterogeneous-Nuclear Ribonucleoprotein KIBA 01/2017
1	RotenoneIBA 01/2017
1	octaneIBA 01/2017
1	ParaquatIBA 01/2017
1	Interferon Type IIBA 01/2017
1	Retinaldehyde (Retinal)IBA 10/2016
1	prolinedithiocarbamate (PDTC)IBA 02/2016
1	NitroimidazolesIBA 10/2015
1	Technetium (Technetium 99m)IBA 10/2015
1	RheniumIBA 10/2015
1	MetalloproteinsIBA 09/2015
1	(2,3-butanedione bis(N(4)- dimethylthiosemicarbazone))zinc(II)IBA 09/2015
1	Huntingtin ProteinIBA 08/2014
1	collapsin response mediator protein-2IBA 08/2014
1	Threonine (L-Threonine)FDA Link 04/2014
1	Therapeutic UsesIBA 12/2013
1	Deferasirox FDA Link 07/2013

Therapy/Procedure

10	Therapeutics 01/2018 - 03/2003